Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Meijer RP"" wg kryterium: Autor


Wyświetlanie 1-12 z 12
Tytuł:
Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor: The PRICELESS-Study-A Qualitative Study.
Autorzy:
Kuiper ST; Julius Center for Health Sciences and Primary Care, General Practice & Nursing Science, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Zweers D; Medical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Suelmann BBM; Medical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Meijer RP; Oncological Urology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Vervoort SCJM; Julius Center for Health Sciences and Primary Care, General Practice & Nursing Science, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Feb 08; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Non-metastatic muscle-invasive bladder cancer: the role of age in receiving treatment with curative intent.
Autorzy:
van Hoogstraten LMC; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Ripping TM; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Aben KKH; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
Pokaż więcej
Corporate Authors:
BlaZIB study group
Źródło:
BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 764-775. Date of Electronic Publication: 2022 Feb 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Urinary Bladder Neoplasms*/surgery
Humans ; Infant ; Cystectomy ; Cohort Studies ; Neoplasm Invasiveness/pathology ; Muscles/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands.
Autorzy:
Flach RN; Department of Oncological Urology, Cancer Center, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
Willemse PM; Department of Oncological Urology, Cancer Center, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
Suelmann BBM; Department of Medical Oncology, Cancer Center, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
Deckers IAG; The Nationwide Network and Registry of Histo- and Cytopathology in The Netherlands (Foundation PALGA), 3991 Houten, The Netherlands.
Jonges TN; Department of Pathology, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
van Dooijeweert C; Department of Pathology, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
van Diest PJ; Department of Pathology, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
Meijer RP; Department of Oncological Urology, Cancer Center, University Medical Centre Utrecht, 3508 Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Oct 27; Vol. 13 (21). Date of Electronic Publication: 2021 Oct 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer.
Autorzy:
Richters A; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Ripping TM; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Leliveld AM; Department of Urology, University Medical Centre Groningen, Groningen, The Netherlands.
van Rhijn BWG; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
Oddens JR; Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Goossens-Laan CA; Department of Urology, Alrijne Hospital, Leiderdorp, The Netherlands.
Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Pokaż więcej
Corporate Authors:
BlaZIB Study Group
Źródło:
BJU international [BJU Int] 2021 Oct; Vol. 128 (4), pp. 511-518. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cystectomy*/methods
Postoperative Complications/*mortality
Urinary Bladder Neoplasms/*mortality
Urinary Bladder Neoplasms/*surgery
Aged ; Aged, 80 and over ; Female ; Hospitals/statistics & numerical data ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Time Factors
Czasopismo naukowe
Tytuł:
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Autorzy:
Abu-Ghanem Y; UCL Division of Surgical and Interventional Science, Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.
Capitanio U; Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
Beisland C; Department of Urology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Järvinen P; Urology, Abdominal Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Stewart GD; Department of Surgery, University of Cambridge, Cambridge, UK.
Gudmundsson E; Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
Lam TBL; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
Marconi L; Department of Urology, Coimbra University Hospital, Coimbra, Portugal.
Fernandéz-Pello S; Department of Urology, Cabueñes University Hospital, Gijón, Spain.
Nisen H; Urology, Abdominal Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Volpe A; Department of Urology, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy.
Ljungberg B; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Klatte T; Department of Surgery, University of Cambridge, Cambridge, UK.; Department of Urology, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK.
Bensalah K; Department of Urology, University Hospital of Rennes, Rennes, France.
Dabestani S; Division of Urological Cancers, Department of Translational Medicine, Central Hospital Kristianstad, Lund University, Lund, Sweden.
Bex A; UCL Division of Surgical and Interventional Science, Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Sep; Vol. 128 (3), pp. 386-394. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Carcinoma, Renal Cell/*surgery
Kidney Neoplasms/*surgery
Nephrectomy/*methods
Aftercare ; Aged ; Carcinoma, Renal Cell/pathology ; Female ; Humans ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Nephrons ; Organ Sparing Treatments ; Retrospective Studies ; Risk Assessment
Czasopismo naukowe
Tytuł:
A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity.
Autorzy:
Wenmaekers S; Laboratory Translational Oncology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.; Department of Oncological Urology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Viergever BJ; Laboratory Translational Oncology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.; Department of Oncological Urology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Kumar G; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
Kranenburg O; Laboratory Translational Oncology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
Meijer RP; Laboratory Translational Oncology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.; Department of Oncological Urology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Cells [Cells] 2021 May 20; Vol. 10 (5). Date of Electronic Publication: 2021 May 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Drug Resistance, Neoplasm*
Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Neoplasms/*drug therapy
Tumor Suppressor Proteins/*metabolism
Ubiquitin-Protein Ligases/*metabolism
Humans ; Neoplasms/genetics ; Neoplasms/metabolism ; Neoplasms/pathology ; Tumor Suppressor Proteins/genetics ; Ubiquitin-Protein Ligases/genetics ; Ubiquitination
Czasopismo naukowe
Tytuł:
Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis.
Autorzy:
Blok JM; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pluim I; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
Daugaard G; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Wagner T; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Jóźwiak K; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Wilthagen EA; Scientific Information Service, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Looijenga LHJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
Bosch JLHR; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
Horenblas S; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Mar; Vol. 125 (3), pp. 355-368. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Carcinoma, Embryonal/*pathology
Neoplasms, Germ Cell and Embryonal/*pathology
Testicular Neoplasms/*pathology
Vascular Neoplasms/*pathology
Humans ; Lymphatic Metastasis ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prognosis ; Risk Factors
SCR Disease Name:
Nonseminomatous germ cell tumor
Czasopismo naukowe
Tytuł:
Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease.
Autorzy:
Blok JM; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Vegt E; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Brouwer OR; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Meijer RP; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bosch JLHR; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Bex A; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Horenblas S; Department of Oncological Urology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2019 Sep; Vol. 124 (3), pp. 424-430. Date of Electronic Publication: 2019 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Sentinel Lymph Node Biopsy*
Testicular Neoplasms/*diagnosis
Testicular Neoplasms/*pathology
Adult ; Early Detection of Cancer ; Feasibility Studies ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Tomography, Emission-Computed, Single-Photon
Czasopismo naukowe
Tytuł:
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone.
Autorzy:
Mertens LS; Department of Urology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Meijer RP
Meinhardt W
van der Poel HG
Bex A
Kerst JM
van der Heijden MS
Bergman AM
Horenblas S
van Rhijn BW
Pokaż więcej
Źródło:
BJU international [BJU Int] 2014 Jul; Vol. 114 (1), pp. 67-74. Date of Electronic Publication: 2014 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/therapy
Lymph Nodes/*pathology
Lymphatic Metastasis/*pathology
Aged ; Antineoplastic Agents/therapeutic use ; Cystectomy/methods ; Disease-Free Survival ; Female ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Pelvis ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.
Autorzy:
Meijer RP; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. />Meinhardt W
van der Poel HG
van Rhijn BW
Kerst JM
Pos FJ
Horenblas S
Bex A
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2013 Aug; Vol. 20 (8), pp. 778-84. Date of Electronic Publication: 2012 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Small Cell/*mortality
Carcinoma, Small Cell/*therapy
Chemoradiotherapy/*methods
Urinary Bladder Neoplasms/*mortality
Urinary Bladder Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Small Cell/pathology ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Risk Factors ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł:
The SURgical PAtient Safety System (SURPASS) checklist optimizes timing of antibiotic prophylaxis.
Autorzy:
de Vries EN; Department of Surgery, Academic Medical Centre, Amsterdam, the Netherlands. .
Dijkstra L
Smorenburg SM
Meijer RP
Boermeester MA
Pokaż więcej
Źródło:
Patient safety in surgery [Patient Saf Surg] 2010 Apr 13; Vol. 4 (1), pp. 6. Date of Electronic Publication: 2010 Apr 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-12 z 12

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies